Related Experiment Video
Updated: Aug 7, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis
T H Taha1, S S Durrant, P K Mazeika
1Department of Medicine (Clinical Cardiology), Hammersmith Hospital, London, UK.
Insights
Low-dose aspirin may prevent embolic complications in infective endocarditis. Patients receiving aspirin showed reduced vegetation size and no stroke events, unlike the control group.
Area of Science:
- Cardiology
- Neurology
- Infectious Diseases
Background:
- Infective endocarditis poses a risk of embolic complications, including stroke.
- Current treatment strategies aim to prevent these serious adverse events.
Purpose of the Study:
- To investigate the potential role of low-dose aspirin in preventing embolic events in patients with infective endocarditis.
- To assess the effect of aspirin on vegetation size and platelet half-life.
Main Methods:
- A preliminary observational study involving nine patients with infective endocarditis.
- Patients were randomized to receive either low-dose aspirin (75 mg/day) or no aspirin.
- Cranial computed tomography (CT) and echocardiography were used to monitor stroke incidence and vegetation area.
- Platelet half-life was measured using Indium-111 radiolabelling.
Main Results:
- No embolic events (stroke, myocardial infarct) occurred in the aspirin group (n=4) compared to three events in the control group (n=5).
- The mean vegetation area decreased in the aspirin group (mean change = -0.24 cm2) but increased in the control group (mean change = +0.35 cm2).
- Platelet half-life tended to be lower in the control group.
Conclusions:
- Adjunctive low-dose aspirin therapy may be beneficial in preventing embolic complications in infective endocarditis.
- Further research is warranted to confirm these preliminary findings.
Abstract:
The incidence of stroke on cranial computed tomography (CT) and change in echocardiographic vegetation area was prospectively compared in a preliminary observational study involving nine patients with infective endocarditis randomized to either low-dose aspirin (75 mg d-1, Group I, n = 4) or no aspirin (Group II, n = 5). Two symptomatic cerebral infarcts and one myocardial infarct occurred in the controls, compared to no events in patients on aspirin during a total observation period of 343 d (range 28-49 d). The mean vegetation area decreased in the aspirin group (mean change = -0.24 cm2), compared to an increase in controls (mean change = +0.35 cm2). The platelet half-life (normal range 5-6 d), which was measured using Indium-111 radiolabelling, tended to be lower in Group II (4.6 +/- 0.2 vs. 3.9 +/- 0.5 d). No side-effects or complications attributable to aspirin were observed. A possible role for adjunctive aspirin therapy in the prevention of embolic complications in infective endocarditis is suggested, and warrants further study.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

